Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results

By Jhaveri F.M.   Zippe C.D.   Klein E.A.   Kupelian P.A.  

Urology, Vol. 54, Iss. 5, 1999-11 ,pp. : 884-890

Elsevier

Access to resources Recommend Favorite

Anatomic radical retropubic prostatectomy—long-term recurrence-free survival rates for localized prostate cancer

By Chun Felix   Graefen Markus   Zacharias Mario   Haese Alexander   Steuber Thomas   Schlomm Thorsten   Walz Jochen   Karakiewicz Pierre   Huland Hartwig  

World Journal of Urology, Vol. 24, Iss. 3, 2006-08 ,pp. : 273-280

Springer Publishing Company

Access to resources Recommend Favorite

Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer

By Dillioglugil O.   Leibman B.D.   Kattan M.W.   Seale-Hawkins C.   Wheeler T.M.   Scardino P.T.  

Urology, Vol. 50, Iss. 1, 1997-07 ,pp. : 93-99

Elsevier

Access to resources Recommend Favorite

What does postradiotherapy PSA nadir tell us about freedom from PSA failure and progression-free survival in patients with low and intermediate-risk localized prostate cancer?

By DeWitt K.D.   Sandler H.M.   Weinberg V.   McLaughlin P.W.   Roach M.  

Urology, Vol. 62, Iss. 3, 2003-09 ,pp. : 492-496

Elsevier

Access to resources Recommend Favorite

Comparison of Radical Prostatectomy and Iodine 125 Interstitial Radiotherapy for the Treatment of Clinically Localized Prostate Cancer: A 7-Year Biochemical (PSA) Progression Analysis - a case-controlled comparison of conservative treatment versus ra

By Polascik T.J.   Pound C.R.   DeWeese T.L.   Walsh P.C.  

Urology, Vol. 51, Iss. 6, 1998-06 ,pp. : 884-890

Elsevier

Access to resources Recommend Favorite